title: Emerging indications for octreotide therapy, Part 2.
authors.affiliation: Raabe College of Pharmacy, Ohio Northern University, Columbus.
authors.forename: K W
authors.initials: KW
authors.lastname: Mosdell
authors.forename: J A
authors.initials: JA
authors.lastname: Visconti
mesh_terms: D000208:Acute Disease; D002908:Chronic Disease; D004377:Dumping Syndrome / Q000188:drug therapy; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D015282:Octreotide / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010182:Pancreatic Diseases / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012778:Short Bowel Syndrome / Q000188:drug therapy
chemical_list: D015282:Octreotide